The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes – An Analysis From The Swedish Health Care Perspective
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.693
https://www.valueinhealthjournal.com/article/S1098-3015(14)02623-0/fulltext
Title :
The Cost-Effectiveness of Exenatide Bid Versus Insulin Lispro Tid As Add-On Therapy to Titrated Insulin Glargine in Patients With Type 2 Diabetes – An Analysis From The Swedish Health Care Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)02623-0&doi=10.1016/j.jval.2014.08.693
First page :
A344
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
115